HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel molecular grading model: combination of Ki67 and VEGF in predicting tumor recurrence and progression in non-invasive urothelial bladder cancer.

AbstractPURPOSE:
To assess efficacy of Ki67 combined with VEGF as a molecular grading model to predict outcomes with non-muscle invasive bladder cancer (NMIBC).
MATERIALS:
72 NMIBC patients who underwent transurethral resection (TUR) followed by routine intravesical instillations were retrospectively analyzed in this study. Univariate and multivariate analyses were performed to confirm the prognostic values of the Ki67 labeling index (LI) and VEGF scoring for tumor recurrence and progression.
RESULTS:
The novel molecular grading model for NMIBC contained three molecular grades including mG1 (Ki67 LI≤25%, VEGF scoring≤8), mG2 (Ki67 LI>25%, VEGF scoring≤8; or Ki67 LI≤25%, VEGF scoring>8), and mG3 (Ki67 LI>25%, VEGF scoring>8), which can indicate favorable, intermediate and poor prognosis, respectively.
CONCLUSIONS:
The described novel molecular grading model utilizing Ki67 LI and VEGF scoring is helpful to effectively and accurately predict outcomes and optimize personal therapy.
AuthorsJun-Xing Chen, Nan Deng, Xu Chen, Ling-Wu Chen, Shao-Peng Qiu, Xiao-Fei Li, Jia-Ping Li
JournalAsian Pacific journal of cancer prevention : APJCP (Asian Pac J Cancer Prev) Vol. 13 Issue 5 Pg. 2229-34 ( 2012) ISSN: 2476-762X [Electronic] Thailand
PMID22901199 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • Ki-67 Antigen
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
Topics
  • Administration, Intravesical
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor (metabolism)
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Humans
  • Immunoenzyme Techniques
  • Ki-67 Antigen (metabolism)
  • Male
  • Middle Aged
  • Models, Statistical
  • Neoplasm Grading
  • Neoplasm Recurrence, Local (metabolism, mortality, pathology)
  • Neoplasm Staging
  • Prognosis
  • Survival Rate
  • Urinary Bladder Neoplasms (metabolism, mortality, pathology)
  • Vascular Endothelial Growth Factor A (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: